Insulet Key Fundamental And Technical Indicators

Stocks . USA . 
Stock . Insulet
PODD Stock  USD 154.16  -6.24  -3.89%   
Insulet's ratios page distills the financial statements into the key efficiency, leverage, and profitability metrics. Insulet has a profit margin of 10.44%. ROE stands at 23.0% while the current ratio, a measure of short-term liquidity, is 4.69. At present, the short-cycle RSI for Insulet is 0, signaling extreme oversold conditions. Deeply oversold conditions like this sometimes attract bargain hunters, but can also persist during prolonged declines.
Momentum
OversoldOverbought
0 · Capitulated
As of the 10th of May, the last recorded price for Insulet is 154.16 per share. Primary technical drivers reflect Standard Deviation of 3.04, risk adjusted performance of -0.21, and Market Risk Adjusted Performance of -1.15. Quantitative analysis incorporates volatility metrics and price behavior to assess directional bias. Metrics are compared to industry averages to assess relative positioning.
Cycles Operators Shifting Impulse Patterns Depth Overlaps Statistics Volatility Volume
Insulet's financial statements serve as the foundation for evaluating earnings quality and balance sheet strength. Key valuation metrics and long-term strategic positioning are highlighted below: Analyzing Insulet's margins, turnover ratios, and leverage metrics provides a structured basis for estimation. Core indicators are listed below:
 Gross Profit
2.06 billion
 Profit Margin
9.6%
 Market Capitalization
10.68 billion
 Enterprise Value Revenue
3.77
 Revenue
2.9 billion
There are currently one hundred twenty fundamental measures for Insulet that can be evaluated and compared over time across peers. Active traders should verify all of Insulet's latest fundamental drivers against the trend between 2010 and 2026 to make sure the company can sustain itself in the future. In the latest reported period, Market Cap remains stable near $9.34 billion. Also, Enterprise Value remains stable near $9.97 billion. Use Equity Screeners to access broader equity screening tools. The framework supports screening across sectors, industries, and market segments.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Profitability
Analysis
Details
Earnings
Projections
Details

Balance Sheet Accounts

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets$3.35 billion$3.19 billion1.4 B
Consistent Growth
Cash$751.9 million$716.1 million419.5 M
Consistent Growth
Other Assets$1.09$1.1524.1 M
High Variability
Cash And Short Term Investments$751.9 million$716.1 million443.2 M
Consistent Growth
Common Stock Shares Outstanding47.63 million71.89 million57.1 M
Moderate Growth
Liabilities And Stockholders Equity$3.35 billion$3.19 billion1.4 B
Consistent Growth
Total Liabilities$1.76 billion$1.68 billion911.1 M
Consistent Growth
Total Current Assets$1.98 billion$1.89 billion823.2 M
Consistent Growth
Short and Long Term Debt Total$529.73 million$1.05 billion665.5 M
Moderate Growth
Total Current Liabilities$714.11 million$680.1 million224.6 M
Consistent Growth
Short Term Debt$21.09 million$22.2 million51 M
High Variability
Property Plant And Equipment Net$906.36 million$863.2 million343.2 M
Consistent Growth
Accounts Payable$78.75 million$75 million29.7 M
Moderate Growth
Non Current Assets Total$1.37 billion$1.3 billion531.3 M
Consistent Growth
Non Current Assets Other$175.66 million$167.3 million66.5 M
Consistent Growth
Common Stock Total Equity$120,750$115,00075 K
Consistent Growth
Non Current Liabilities Total$555.38 million$995.1 million659.7 M
Moderate Growth
Property, Plant and Equipment (Gross)$1.31 billion$1.25 billion447.7 M
Consistent Growth
Common Stock$64,100$115,00071.7 K
Moderate Growth
Other Liabilities$5.42 million$9.54 million6.6 M
Moderate Growth
Long Term Debt$581.54 million$930.8 million640.9 M
Moderate Growth
Net Receivables$542.75 million$516.9 million155.8 M
Consistent Growth
Inventory$475.23 million$452.6 million168.8 M
Consistent Growth
Property Plant Equipment$724.38 million$689.88 million306.1 M
Consistent Growth
Good Will$45.75 million$51.6 million41 M
Consistent Growth
Long Term Debt Total$1.66 billion$1.58 billion754 M
Consistent Growth
Capital Surplus$899.06 million$1.2 billion852.8 M
Consistent Growth
Non Current Liabilities Other$67.41 million$64.2 million20.3 M
Consistent Growth
Intangible Assets$122.95 million$117.1 million42.4 M
Moderate Growth
Capital Lease Obligations$229,995$242,1001.6 M
Moderate Decline
Short and Long Term Debt$17.48 million$18.4 million129.7 M
High Variability
Net Invested Capital$1.71 billion$2.46 billion1.2 B
Consistent Growth
Net Working Capital$983.86 million$1.23 billion717.2 M
Moderate Growth
Capital Stock$104,363$115,00079.4 K
Consistent Growth

Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Other Operating Expenses$2.35 billion$2.23 billion843 M
Consistent Growth
Research Development$316.15 million$301.1 million119.3 M
Consistent Growth
Total Operating Expenses$1.54 billion$1.47 billion530.3 M
Consistent Growth
Selling And Marketing Expenses$74.52 million$96.94 million75.1 M
High Variability
Depreciation And Amortization$118.75 million$113.1 million40.7 M
Consistent Growth
Selling General Administrative$1.22 billion$1.17 billion350.8 M
Consistent Growth
Total Revenue$2.84 billion$2.71 billion936.8 M
Consistent Growth
Cost Of Revenue$806.61 million$768.2 million312.8 M
Consistent Growth
Interest Income$36.44 million$34.7 million15.4 M
High Variability
Reconciled Depreciation$58.03 million$90.4 million37 M
Consistent Growth

Cash Flow Statement Items

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow$1 billion$953.4 million382.7 M
Consistent Growth
Depreciation$94.92 million$90.4 million38 M
Consistent Growth
Capital Expenditures$201.18 million$191.6 million89.8 M
Consistent Growth
End Period Cash Flow$751.9 million$716.1 million404.7 M
Consistent Growth
Change To Liabilities$158.79 million$151.22 million51.9 M
Consistent Growth
Stock Based Compensation$65.83 million$62.7 million32.5 M
Consistent Growth
Change To Netincome$40.71 million$55.09 million38 M
Moderate Growth

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio7.01x7.38x14.8419
High Variability
Days Sales Outstanding73.669.6759.025
High Variability
Stock Based Compensation To Revenue0.02x0.02x0.0495
Moderate Decline
Capex To Depreciation$3.19$2.123.0664
High Variability
EV To Sales7.13x7.51x17.6898
High Variability
Inventory Turnover1.611.74.6556
Moderate Decline
Days Of Inventory On Hand225.8215.05149
Moderate Growth
Payables Turnover8.1710.2411.0475
High Variability
Sales General And Administrative To Revenue0.41x0.43x11.3195
High Variability
Research And Ddevelopement To Revenue0.11x0.11x12.79
High Variability
Capex To Revenue0.07x0.07x6.5341
High Variability
Cash Per Share16.0510.1810.5551
High Variability
Days Payables Outstanding66.6735.6461.8095
High Variability
Intangibles To Total Assets$0.05$0.050.1135
Consistent Decline
Current Ratio2.642.7827.1144
High Variability
Receivables Turnover4.945.246.8481
High Variability
Graham Number$43.32$41.2611.492
Moderate Growth
Capex Per Share3.172.721.9436
High Variability
Average Receivables$24.57 million$29.86 million31.6 M
Stable
Revenue Per Share40.4238.514.1355
Consistent Growth
Interest-Bearing Debt Per Share8.6216.0710.7239
Moderate Growth
Debt To Assets0.41x0.33x0.542
High Variability
Operating Cycle$270.69$284.72258
High Variability
Days Of Payables Outstanding66.6735.6461.8095
High Variability
Ebt Per Ebit$0.68$0.721.337
High Variability
Quick Ratio2.012.1126.5412
High Variability
Net Income Per EBT$1.03$0.730.9413
Moderate Variation
Cash Ratio11.0525.4067
High Variability
Cash Conversion Cycle$204.01$249.08196
High Variability
Days Of Inventory Outstanding225.8215.05149
Moderate Growth
Days Of Sales Outstanding73.669.6759.025
High Variability
Fixed Asset Turnover4.363.144.2761
High Variability
Debt Ratio0.410.330.542
High Variability
Price Sales Ratio7.01x7.38x14.8419
High Variability
Asset Turnover0.470.850.6728
High Variability

Valuation Indicators

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap$9.8 billion$9.34 billion7.1 B
Moderate Growth
Enterprise Value$10.47 billion$9.97 billion7.6 B
Moderate Growth

Core Fundamental Drivers

Forward Price Earnings23.9808
Cash And Short Term Investments716.1 million

Return On Equity TTM Driver Correlations

The correlation structure highlights which of Insulet's financial accounts move most closely with changes in Return On Equity TTM. Accounts with strong positive correlation tend to respond to the same operating conditions at Insulet.
Click cells to compare fundamentals
Competition

Insulet Accumulated Other Comprehensive Income

Accumulated Other Comprehensive Income

$13.86 million
Accumulated Other Comprehensive Income stood at $13.2 million as of December 31, 2025.

Insulet Fundamental Drivers Relationships

ROE stood at 0.17 as of December 31, 2025. Related reported metric: Return On Asset TTM at 8.13% as of December 31, 2025.

Main Technical Indicators as of May 10, 2026

Cycle Indicators
Math Operators
Math Transform
Momentum Indicators
Overlap Studies
Pattern Recognition
Price Transform
Statistic Functions
Volatility Indicators
Volume Indicators
Risk Adjusted Performance-0.21
Market Risk Adjusted Performance-1.15
Mean Deviation2.01
Coefficient Of Variation-439.75
Standard Deviation3.04
Variance9.22
Information Ratio-0.23
Jensen Alpha-0.70
Total Risk Alpha-0.69
Treynor Ratio-1.16
Maximum Drawdown17.27
Value At Risk-4.53
Potential Upside3.1
Skewness-0.91
Kurtosis4.14

Daily Market Strength Indicators

Market strength indicators for Insulet quantify how the stock responds to shifts in volume and sentiment. These indicators capture shifts in momentum that may precede significant price moves in Insulet. The Market Facilitation Index measures how efficiently price moves relative to volume — rising MFI with rising volume signals strong trend participation. Monitoring these indicators for Insulet through complete market cycles reveals recurring patterns.
Accumulation Distribution0.0647
Daily Balance Of Power-0.59
Rate Of Daily Change0.96
Day Median Price159.33
Day Typical Price157.61
Market Facilitation Index10.66
Price Action Indicator-8.29
Period Momentum Indicator-6.24

Basic Forecasting Models

Bollinger Bands applied to Insulet Stock price data measure how far Insulet has deviated from its recent average relative to its own volatility. This distinction drives the choice of forecasting model applied to Insulet's price data. On-balance volume for Insulet Stock creates a running indicator of buying versus selling pressure in Insulet. Price departures from the channel boundary often mean-revert, offering tactical signals for Insulet's.
Naive Prediction
Simple Exponential Smoothing
Double Exponential Smoothing
Triple Exponential Smoothing
Simple Regression
Polynomial Regression
Simple Moving Average
4 Period Moving Average
8 Period Moving Average
20 Period Moving Average

Insulet Related Equities

These stocks within the Health Care space are often compared to Insulet by analysts and fund managers in the sector. Checking Insulet against peers on P/E, margins, and return on equity helps put its position in context. Persistent outperformance or underperformance by specific peers relative to Insulet often signals structural advantages or weaknesses. These checks provide a starting point for deeper study of Insulet's strengths and weak spots.
 Risk & Return  Correlation

Return On Equity TTM Peer Comparison

Peer-based analysis of Insulet on Return On Equity TTM allows investors to benchmark performance against similar stocks. A favorable Insulet's Return On Equity TTM compared to competitors can indicate undervaluation or a stronger fundamental position. Outlier Return On Equity TTM values among Insulet peers often point to structural differences in business models. This analysis benchmarks Insulet against the most relevant set of comparable stocks.
Insulet is currently under evaluation for return on equity ttm relative to top peers.

Important Fundamentals

Return On Equity TTM0.23
Return On Asset TTM0.0974
Profit Margin TTM0.1
Operating Margin TTM0.16
Current Valuation10.95 B
Shares Outstanding69.26 M
Shares Owned By Insiders0.31 %
Shares Owned By Institutions99.69 %
Number Of Shares Shorted2.7 M
Price To Book TTM8.04 X
Price To Sales TTM3.68 X
Revenue TTM2.71 B
Gross Profit TTM2.06 B
EBITDA TTM586.9 M
Net Income TTM247.1 M
Cash And Equivalents TTM708.6 M
Cash Per Share TTM10.21 X
Total Debt TTM1.05 B
Debt To Equity TTM3.34 %
Current Ratio TTM4.69 X
Book Value Per Share TTM21.53 X
Cash Flow From Operations TTM569.3 M
Short Ratio TTM3.10 X
Earnings Per Share4.28 X
Price To Earnings To Growth0.84 X
Target Price264.17
Number Of Employees5.4 K
Trailing Beta1.2
Market Capitalization TTM10.68 B
Total Asset TTM3.19 B
Retained Earnings TTM287.4 M
Working Capital TTM1.23 B
Current Asset TTM190.76 M
Current Liabilities TTM65.16 M
Net Asset3.19 B

Financial Metrics, Fundamentals & Methodology

Core financial indicators for Insulet help show whether operating productivity is strengthening or weakening. Cash-flow trends help test whether reported earnings are being backed by real operating performance. Latest reported fundamentals for Insulet include revenue of 2.71 billion, positive EPS of 4.28, operating margin of 16.03%, current ratio of 4.69 as of the latest reporting period.

Insulet data is compiled from periodic company reporting and market reference feeds and standardized for comparability. Professional analyst research is incorporated when coverage is available. Financial statement fields are presented under issuer-reported GAAP or IFRS accounting conventions.

Editorial review and methodology oversight provided by: Gabriel Shpitalnik, Member of Macroaxis Editorial Board


 
Tools
Analysis
Directory
Company
2026 Macroaxis LLC Made with in San Francisco
Privacy Terms Widgets Feedback
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and conditions page.